Evidence map›Paper›PMID 28931680›Full record

ArticleJournal of virology2017

Molecular Evolution of Herpes Simplex Virus 2 Complete Genomes: Comparison between Primary and Recurrent Infections.

Miguel A Minaya, Travis L Jensen, Johannes B Goll, Maria Korom, Sree H Datla, Robert B Belshe, Lynda A Morrison

Open access · bronzeAbstract readComparative Study
In one paragraph

Article in Journal of virology, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed
2.8field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 26 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. Review
  7. Alphaherpesvirus Genomics: Past, Present and Future.Current issues in molecular biology · 2021
    Review
  8. Article
  9. Virus evolution · 2020
    Article
  10. Article
  11. Review
  12. Article
  13. Article
  14. Article
  15. Article
  16. Review
  17. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

Miguel A MinayaDepartment of Molecular Microbiology and Immunology, Saint Louis University School of Medicine, St. Louis, Missouri, USA miguel.minaya@health.slu.edu lynda.morrison@health.slu.edu.
Travis L JensenThe EMMES Corporation, Rockville, Maryland, USA.
Johannes B GollThe EMMES Corporation, Rockville, Maryland, USA.
Maria KoromDepartment of Molecular Microbiology and Immunology, Saint Louis University School of Medicine, St. Louis, Missouri, USA.
Sree H DatlaDepartment of Molecular Microbiology and Immunology, Saint Louis University School of Medicine, St. Louis, Missouri, USA.
Robert B BelsheDepartment of Internal Medicine, Saint Louis University School of Medicine, St. Louis, Missouri, USA.
Lynda A MorrisonDepartment of Molecular Microbiology and Immunology, Saint Louis University School of Medicine, St. Louis, Missouri, USA miguel.minaya@health.slu.edu lynda.morrison@health.slu.edu.
Saint Louis University · USEmmes (United States) · US

Funding

Washington University Institute of Clinical and Translational Sciences (UL1)UL1RR024992 · NCRR · WASHINGTON UNIVERSITY · PI EVANOFF, BRADLEY A · 2007 to 2011
$45.4M
NCRR NIH HHS UL1 RR024992NIAID NIH HHS HHSN272200800003CNIAID NIH HHS HHSN272201300021CNIAID NIH HHS HHSN272201300021I
6 · The paper itself

Abstract

Herpes simplex virus 1 (HSV-1) and HSV-2 are large, double-stranded DNA viruses that cause lifelong persistent infections characterized by periods of quiescence and recurrent disease. How HSV evolves within an infected individual experiencing multiple episodes of recurrent disease over time is not known. We determined the genome sequences of viruses isolated from two subjects in the Herpevac Trial for Women who experienced primary HSV-2 genital disease and compared them with sequences of viruses isolated from the subsequent fifth or sixth episode of recurrent disease in the same individuals. Each of the HSV-2 genome sequences was initially obtained using next-generation sequencing and completed with Sanger sequencing. Polymorphisms over the entire genomes were mapped, and amino acid variants resulting from nonsynonymous changes were analyzed based on the secondary and tertiary structures of a previously crystallized protein. A phylogenetic reconstruction was used to assess relationships among the four HSV-2 samples, other North American sequences, and reference sequences. Little genetic drift was detected in viruses shed by the same subjects following repeated reactivation events, suggesting strong selective pressure on the viral genome to maintain sequence fidelity during reactivations from its latent state within an individual host. Our results also demonstrate that some primary HSV-2 isolates from North America more closely resemble the HG52 laboratory strain from Scotland than the low-passage-number clinical isolate SD90e from South Africa or laboratory strain 333. Thus, one of the sequences reported here would be a logical choice as a reference strain for inclusion in future studies of North American HSV-2 isolates.

Indexed as

Evolution, MolecularGenome, ViralClinical Trials as TopicDNA, ViralFemaleGenetic DriftHerpes GenitalisHerpesvirus 2, HumanHigh-Throughput Nucleotide SequencingHumansINDEL MutationNorth AmericaPhylogenyPolymorphism, GeneticRecurrenceScotlandDNA, Viralcomplete genomeevolutionary biologygenetic polymorphismsherpes simplex virusHerpevac Trial for Womennext-generation sequencing

Identifiers

PMID28931680
PMCPMC5686715
OpenAlexW2755044609

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.